Author: CLAHRC

NIHR logo

Posted on by CLAHRC

This page contains digital quality, downloadable logos for the NIHR

Read NIHR Guidance on the use of the NIHR logo

NIHR colour logo

This logo is for use on white or light backgrounds.

NIHR reversed logo

This logo is for use only on a background of NIHR navy, as illustrated below.

NIHR black logo

This logo is for use in black-and-white or greyscale materials, against white or light backgrounds.

NIHR white logo

This logo is for use on dark backgrounds, as illustrated below.

CLAHRC logo

Posted on by CLAHRC

We have been allocated a CLAHRC North Thames logo, designed by the NIHR.

The guidance on use and position of the CLAHRC logo is the same as for the NIHR logo

Below are different types of downloadable files in various formats

Read NIHR guidance on the use of this logo

CLAHRC colour logo

CLAHRC Colour Logo (PNG File)

CLAHRC Colour Logo (JPG File)

This logo is for use on white or light background

CLAHRC black logo

CLAHRC Black Logo (PNG FIle)

CLAHRC Black Logo (JPG File)

This logo is for use in black-and-white or greyscale materials, against white or light backgrounds.

CLAHRC Reversed Logo

CLAHRC Reversed Logo (PNG File)

This logo is for use only on a background of NIHR navy.

CLAHRC White Logo

CLAHRC White Logo (JPG File)

This logo is for use on dark backgrounds.

NIHR and CLAHRC logos, branding and identity guidance

Posted on by CLAHRC

Welcome to NIHR’s new visual identity

We are pleased to tell you that the NIHR has introduced a new, independent visual identity, including a new CLAHRC North Thames logo to reflect the breadth of its work across public health and the nation’s health and care system.

We have already adopted the new visual identity on our primary digital channels (website and social media) and, by mid-May, channels managed by the wider NIHR will have migrated to the new identity. 

May will also see the launch of a new audience-centred NIHR website that fully expresses the Institute’s new identity.

Acknowledging NIHR funding

You’ll find everything you need to know about the new visual identity in the NIHR’s new guidelines at www.nihr.ac.uk/branding and https://www.nihr.ac.uk/about-us/resources/branding/brand-elements/. 

As part of the new identity, the NIHR is keen for researchers to show they are funded/supported by NIHR. 

Please note that from 1 January 2020, printed (and digital) materials featuring the old NIHR logo with the NHS lozenge, italicised or not and colour bar, may no longer be used.

Download the files below

CLAHRC logo

NIHR logo

NIHR Supported and Funded by logos

Mechanical thrombectomy is cost-effective up to 24 hours from stroke

Posted on by CLAHRC

CLAHRC researchers demonstrate the value of intervention beyond the current recommended 6 hours

Ischaemic stroke is the most common type of stroke, occurring when a blood clot blocks an artery cutting blood flow to part of the brain. Stroke can lead to coma, severe disability and eventually death if not treated promptly. 

Mechanical clot retrieval (thrombectomy) is an intervention to remove clots when the current medical treatment (thrombolysis) is not sufficient to dissolve them.

Thrombectomy to remove a clot

Current guidance from NHS England and the National Institute for Health and Care Excellence (NICE) (see below) only supports this intervention within 6 hours from stroke onset.

NHS England – Clinical Commissioning Policy on Mechanical Thrombectomy for Acute Ischaemic Stroke.

NICE – Mechanical thrombectomy devices for acute ischemic stroke. Guidance MIB153. 30 July 2018 

Our researchers compared the cost-utility of mechanical thrombectomy (MT) in addition to medical treatment versus medical treatment alone performed beyond 6 hours from stroke onset in the NHS.

Our research, published in the International Journal of Stroke, shows that MT is still cost-effective if performed up to 24 hours. The publication is now cited as health economics evidence in the latest NICE evidence review (Stroke (Update). Evidence review D: thrombectomy- Draft for consultation). and has been used to recommend the offer of MT up to 24 hours. 

The work demonstrates mechanical thrombectomy is cost-effective up to 24 hours from acute ischemic stroke symptom onset – we propose the NHS implements this intervention on the basis of improvement in the quality of life of patients as well as economic grounds.

Pizzo, E., Dumba, M., & Lobotesis, K. (2019).
Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke.
International Journal of Stroke
https://doi.org/10.1177/1747493019830587

Registration Open

Posted on by CLAHRC

Rethinking Cancer UCL Cancer Domain Symposium

Monday 13 May 2019

UCL Institute of Education

Registration for the inaugural UCL Cancer Domain Symposium is open

Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.

This symposium, organised by the UCL Cancer Domain, invites our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives. The event showcases our distinctive multidisciplinary expertise and features interactive discussion sessions with our speakers and panels. Talks are scheduled on the following themes:

  • Cancer evolution: can we beat Nature?
  • Cancer detection: the earlier the better?
  • The cancer treatment revolution and how we afford it

We are delighted to announce that Professor Charles Swanton (UCL Cancer Institute and Francis Crick Institute) and Professor Mariana Mazzucato (UCL Institute for Innovation and Public Purpose) will deliver the keynote lectures at this event.


Register your place here: https://ucl-cancer-domain-symposium-2019.eventbrite.com

Join the conversation by tweeting us @UCL_SLMS using the hashtag #UCLCancerDomain

Introduction to Evaluation Online: 7th May – 4th June 2019

Posted on by CLAHRC

Do you need to demonstrate the impact of projects in your organisation?

Do you want to improve the design and implementation of your programmes?

Are you tasked with carrying out an evaluation, but don’t know where to start?

Consider enrolling in our four-week online course run by the NIHR CLAHRC North Thames Academy to address these challenges. This course has been recently updated. It is aimed at staff in frontline services at NHS Trusts, CCGs and Local Authorities, who have limited experience conducting service evaluations and would like to learn about evaluations in flexible time.

After participating in this course, you will have the skills and knowledge to undertake your own evaluation of a local programme or service. Inspired by the content of our popular face-to-face evaluation course, the online course will cover:

  • Different types of evaluation, including their pros and cons
  • How to select suitable methods and approaches for evaluating a local programme or service
  • Practical skills and tips in using evaluation methods and approaches
  • Ways of sharing your evaluation findings to make an impact

Teaching will be delivered entirely online. You’ll learn by watching videos and lecture slides; interacting through activities and questions; and learning from others by taking part in the discussions that accompany each step. You’ll also develop a plan for a real life evaluation you may have to conduct. 

Who is this workshop suitable for?

Staff from NHS trusts, local authorities and clinical commissioning groups who need to evaluate local programmes or services as part of their work. The course is not aimed at academics or researchers.

What preparation is needed?

Participants should attend the course with an evaluation in mind that they may have to carry out.  No previous knowledge of evaluation is required, or experience of study design and statistics.

Participants will receive a certificate of completion if they undertake at least 80% of the course activities.

Dates – Tuesday 7th May – Tuesday 4th June 2019.

Learning hours – an estimate of 3 hours per week (12 hours in total)

Cost – £100 for staff working in NIHR CLAHRC North Thames partner organisations (please click here to see a list of our partners). There is a delegate fee of £250 for other attendees.

Registration – Registration will open between 25th February and 3rd May 2019.
To register for this course, please go to the UCL online store.

For more information please contact clahrc.academy@ucl.ac.uk

Dr Helen Barratt

Posted on by CLAHRC

Helen is a consultant in public health medicine and a health services researcher. She is a member of the CLAHRC research partnership team, and Deputy Director of the CLAHRC Academy. Her research uses qualitative and quantitative methods to evaluate health care and public health services.

Bart’s Research Centre for Women’s Health is up and running with the EMmY study

Posted on by CLAHRC

We’re delighted to announce our latest research partnership – with the the Bart’s Research Centre for Women’s Health (BARC) .

BARC was launched in June 2017 and is led by Professors Shakila Thangaratinam and Khalid Khan.

The Centre is funded by Barts Charity and based within Queen Mary University of London at the Whitechapel campus.

The centre team (pictured above) will focus on improving the health of mothers and babies in East London, addressing healthcare challenges such as diabetes, obesity and heavy blood loss during childbirth.

The first BARC study is set to start in January 2018 –  “EMmY: Effectiveness and acceptability of myo-inositol nutritional supplement in the prevention of gestational diabetes: a pilot placebo controlled double blind randomised trial”.

EmMY will aim to randomise 200 women who are at risk of developing gestational diabetes, across three sites (Barts Health, Guy’s and St Thomas’, and Central Manchester University NHS Trusts).

Participants will be randomised to receive either 4g of Myo-inositol – a naturally occurring substance produced in the human body that belongs to the vitamin B complex group – or placebo study supplement daily, from the end of the first trimester until delivery.

The pilot will examine rates of recruitment and randomisation to the trial, and rates of adherence to the intervention. Researchers will analyse reasons for participation, non-participation, and non-adherence to the trial protocol. Any preliminary estimates and insight into trial procedures from the EMmY study will then inform a future large-scale trial.

The CLAHRC is supporting the study by providing health economic analysis for the pilot and full trial and assisting with patient and public involvement..

Contact Doris Lanz, BARC Senior Trial Manager for more info at d.lanz@qmul.ac.uk